Imidazole-containing farnesyltransferase inhibitors: 3D quantitative structure-activity relationships and molecular docking.
One of the most promising anticancer and recent antimalarial targets is the heterodimeric zinc-containing protein farnesyltransferase (FT). In this work, we studied a highly diverse series of 192 Abbott-initiated imidazole-containing compounds and their FT inhibitory activities using 3D-QSAR and docking, in order to gain understanding of the interaction of these inhibitors with FT to aid development of a rational strategy for further lead optimization. We report several highly significant and predictive CoMFA and CoMSIA models. The best model, composed of CoMFA steric and electrostatic fields combined with CoMSIA hydrophobic and H-bond acceptor fields, had r (2) = 0.878, q (2) = 0.630, and r (pred) (2) = 0.614. Docking studies on the statistical outliers revealed that some of them had a different binding mode in the FT active site based on steric bulk and available active site space, explaining why the predicted activities differed from the experimental activities.
Xie
Aihua
A
Department of Medicinal Chemistry, University of Mississippi, University, MS 38677-1848, USA.
Odde
Srinivas
S
Prasanna
Sivaprakasam
S
Doerksen
Robert J
RJ
D000818:Animals; D004791:Enzyme Inhibitors / Q000737:chemistry* / Q000378:metabolism*; D051231:Farnesyltranstransferase / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D007093:Imidazoles / Q000737:chemistry*; D008958:Models, Molecular; D015394:Molecular Structure; D011485:Protein Binding; D021281:Quantitative Structure-Activity Relationship; D051381:Rats
D004791:Enzyme Inhibitors; D007093:Imidazoles; C029899:imidazole; D051231:Farnesyltranstransferase